Relationship between longitudinal changes in lipid composition and ischemic stroke among hypertensive patients

BACKGROUND Dyslipidemia was strongly linked to stroke,however the relationship between dyslipidemia and its components and ischemic stroke remained unexplained.AIM To investigate the link between longitudinal changes in lipid profiles and dyslipidemia and ischemic stroke in a hypertensive population.METHODS Between 2013 and 2014,6094 hypertension individuals were included in this,and ischemic stroke cases were documented to the end of 2018.Longitudinal changes of lipid were stratified into four groups:(1)Normal was transformed into normal group;(2)Abnormal was transformed into normal group;(3)Normal was transformed into abnormal group;and(4)Abnormal was transformed into abnormal group.To examine the link between longitudinal changes in dyslipidemia along with its components and the risk of ischemic stroke,we utilized multivariate Cox proportional hazards models with hazard ratio(HR)and 95%CI.RESULTS The average age of the participants was 62.32 years±13.00 years,with 329 women making up 54.0%of the sample.Over the course of a mean follow-up of 4.8 years,143 ischemic strokes happened.When normal was transformed into normal group was used as a reference,after full adjustments,the HR for dyslipidemia and ischemic stroke among abnormal was transformed into normal group,normal was transformed into abnormal group and abnormal was transformed into abnormal Wei CC et al.Dyslipidemia changed and ischemic stroke WJCC https://www.wjgnet.com 2 February 6,2025 Volume 13 Issue 4 group were 1.089(95%CI:0.598-1.982;P=0.779),2.369(95%CI:1.424-3.941;P<0.001)and 1.448(95%CI:1.002-2.298;P=0.047)(P for trend was 0.233),respectively.CONCLUSION In individuals with hypertension,longitudinal shifts from normal to abnormal in dyslipidemia-particularly in total and low-density lipoprotein cholesterol-were significantly associated with the risk of ischemic stroke.

Simple anthropometric measurements to predict dyslipidemias in Mexican school-age children: a cross-sectional study

Objective: The purpose of this study was to identify the best predictors of dyslipidemias in Mexican obese children using different anthropometric and body composition measurements. Methods: In an observational, cross-sectional study, 905 children from 5 schools were measured for weight, height, waist and hip circumference, and triceps and subscapular skinfolds. A fasting blood sample was taken from a random sub-sample of 306 children to determine lipid profile. Abnormal total cholesterol, LDL, HDL, triglycerides, total cholesterol to HDL ratio, and LDL to HDL ratio, were determined. Logistic regressions and ROC analysis were carried out to determine the best anthropometric predictors of these risk factors. Results: Prevalence of elevated total cholesterol, triglycerides and LDL cholesterol was 14%, 56% and 58%, respectively. In logistic regressions, BMI and triceps skinfold had the highest odds ratios to predict elevated total cholesterol (1.05, 95%CI: 0.97 - 1.14;1.07, 1.01 - 1.13, respectively), triglycerides (1.19, 1.11 - 1.27;1.12, 1.08 - 1.17, respectively), LDL cholesterol (1.11, 1.04 - 1.18;1.09, 1.05 - 1.14, respectively), total cholesterol to HDL ratio (1.06, 1.00-1.14;1.07,1.03-1.12, respectively) and LDL to HDL ratio risk (1.08,1.01-1.15;1.07, 1.03-1.12, respectively). After BMI and triceps skinfold, subscapular skinfold also predicted dyslipidemias, except for low HDL;both skinfolds had a narrower odds ratio confidence interval than BMI. In ROC analysis, subscapular skinfold was the best predictor of elevated triglycerides with an AUC ≥ 0.7. Conclusion: Anthropometric measurements are not strongly associated with dyslipidemias in Mexican children. However, since triceps and subscapular skinfolds were better predictors than other anthropometry measures, they may be a simple way to predict dyslipidemias in Mexican children.

平胃胶囊对恶变后GES-1细胞氧化应激的抑制作用及机制研究

目的:观察平胃胶囊对亚硝酸胺类化合物N-甲基-N’-硝基-N-亚硝基胍(N-methyl-N’-nitro-N-nitrosoguanidine,MNNG)诱导的胃癌前病变(precancerous lesions of gastric cancer,PLGC)细胞模型的影响,并初步探讨其作用机制。方法:制备空白血清和平胃胶囊含药血清备用;MNNG诱导人胃黏膜上皮细胞系GES-1制备PLGC细胞模型,采用倒置显微镜观察细胞形态,免疫荧光法检测增殖细胞相关抗原Ki67的表达水平,进行模型评价。CCK-8法筛选含药血清最佳干预浓度及时间;采用荧光探针DCFH-DA检测细胞内活性氧(reactive oxygen species,ROS)含量;ELISA检测丙二醛(malondialdehyde,MDA)含量;采用相关试剂盒检测超氧化物歧化酶(superoxide dismutase,SOD)和谷胱甘肽过氧化物酶(glutathione peroxidase,GSH-Px)活性;采用新型荧光探针JC-10检测细胞线粒体膜电位的变化;采用实时荧光定量PCR检测Ki67和黑色素瘤分化相关基因7(melanoma differentiation-associated gene-7,MDA-7)的mRNA表达水平;采用Western blot法测定Ki67、白细胞介素6(interleukin-6,IL-6)和MDA-7的蛋白表达水平。结果:与正常组相比,模型组和空白血清组ROS和MDA含量显著升高(P<0.01),SOD和GSH-Px的活性显著降低(P<0.01),线粒体膜电位显著下降(P<0.01),Ki67和IL-6蛋白表达显著升高(P<0.01),MDA-7蛋白表达显著下降(P<0.01);与空白血清组相比,模型组ROS和MDA含量,SOD和GSH-Px活性,Ki67和MDA-7 mRNA表达水平,Ki67、IL-6和MDA-7蛋白表达水平,以及线粒体膜电位均无显著差异(P>0.05);与空白血清组相比,平胃胶囊含药血清组中ROS和MDA含量显著降低(P<0.01),SOD和GSH-Px活性显著上升(P<0.05),线粒体膜电位显著升高(P<0.01),Ki67和IL-6蛋白表达水平显著下降(P<0.01),MDA-7的mRNA及蛋白表达水平显著升高(P<0.01)。结论:平胃胶囊可显著减轻MNNG诱导的胃黏膜上皮细胞氧化应激损伤和炎症反应,调控促癌基因和抑癌基因的表达,从而发挥防治PLGC的作用。

Impacts of Types and Degree of Obesity on Non-Alcoholic Fatty Liver Disease and Related Dyslipidemia in Chinese School-Age Children?

Objective To explore the impacts of types and degree of obesity on non‐alcoholic fatty liver disease （NAFLD） and related lipids disturbance in Chinese school‐age children. Methods A total of 1 452 school‐age Children of 7 to 17 years were recruited in Beijing with representative cluster sampling method. Data of anthropometric measurements including weight, height and waist circumference were collected from March to May of 2007. Body mass index（BMI）was calculated. Blood samples were obtained and lipid profiles including triglyceride （TG）, total cholesterol （TC）, high‐density lipoprotein cholesterol （HDL‐C） and low‐density lipoprotein cholesterol （LDL‐C） were measured, while glutamate‐pyruvate transaminase （ALT） and glutamic‐oxalacetic transaminase （AST） were determined to evaluate liver function. The liver was also scanned by sonography, and abnormal hepatic sonograms were documented. NAFLD was diagnosed according to the criteria recommended by the Fatty Liver and Alcoholic Liver Disease Study Group under the Chinese Liver Disease Association. Analysis of covariance （ANOVA）, Chi‐square test for trend and binary logistic regression analysis were performed. Results The dyslipidemia and ultrasonographic fatty liver deteriorated with the degree of obesity defined either by BMI or waist circumference. Compared with BMI, waist circumference contributed more to the development of dyslipidemia, fatty liver and NAFLD. The highest levels of TG, TC, LDL‐C, and lowest level of HDL‐C were seen in the mixed obese group followed by abdominal obese, peripheral obese and non‐obese ones. Adjusted for gender and age, the odds ratios （ORs） and their 95% confidence intervals of peripheral obesity, abdominal obesity and mixed obesity were 0, 10.93 （0.98‐121.96） and 79.16 （10.95‐572.44） for predicting NAFLD; 12.61 （1.24‐127.78）, 19.39 （5.23‐71.85）, and 93.21 （29.56‐293.90） for predicting ultrasonographic fatty liver; 1.78 （0.59‐5.44）, 3.01 （1.91‐4.77）, and 4.64 （3.52‐6.12） for predicting dyslipidemia, respectively compared with the non‐obese control group. The trend of hazards over groups was statistically significant （P0.01）. Conclusion The levels of lipid profile and the prevalence of NAFLD and dyslipidemia increased in parallel with the degree of obesity; As compared with the non‐obese control, the mixed obesity had the strongest association with NAFLD and dyslipidemia, followed by abdominal obesity and peripheral obesity in Chinese school‐age Children.

Management of diabetic dyslipidemia: An update

Diabetic dyslipidemia is a cluster of lipoprotein abnormalities characterized by increased triglyceride level, decreased high-density lipoprotein-cholesterol levels and increase in small dense low-density lipoprotein(LDL) particles. It is extremely common in type 2 diabetes(T2DM) affecting around 70 % of patients.Diabetic is a significant risk factor for atherosclerotic cardiovascular disease(ASCVD) which is the most common cause of death in the United States and LDL-cholesterol is the number 1 predictor of ASCVD events in T2DM. The purpose of this review is to discuss the pathophysiology and treatment of diabetic dyslipidemia. In this review, we have discussed both nonpharmacological and pharmacological treatment modalities including major treatment trials which have impacted the cardiovascular outcomes in patients with diabetes. Statin therapy is the mainstay of treatment to reduce ASCVD by decreasing LDL-C by 30%-49% or at least 50% depending on risk level. Attractive adjunctive therapies include Ezetimibe which is more cost effective and PCSK9 inhibitors which display potent LDL-cholesterol lowering and ASCVD event reduction. For severe hypertriglyceridemia, to avert the risk of pancreatitis, both fish oil and fenofibrate in concert with diet is the best strategy.

Relationship between Dyslipidemia and Gene Polymorphism in Tibetan Population

Objective To investigate the relationship between SNPs reported in previous studies and the blood lipid level in the Tibetan population. Methods Random cluster sampling was employed in 5 areas （Lhasa, Shigatse, Shannan, Nagqu, and Nyingchi）. The levels of cholesterol （TC）, triglyceride {TG）, high-density lipoprotein cholesterol （HDL-C）, and low-density lipoprotein cholesterol （LDL-C） from blood samples were determined and DNA was extracted for genotyping and statistical analyses. Results Among 1 318 subjects aged 〉18 years enrolled in this study, 367 had dyslipidemia with a prevalence of 27.8%, of whom dyslipidemia males accounted for 33.1% and dyslipidemia females - 24.5%. Results of the correlation analysis between all SNPs and TG showed that the SNPs of rs714052 and rs964184 were related to the serum TG level. Subjects with rs714052 CC genotype had the lowest TG level, and the highest TG level was found in those with rs714052 TT genotype. The serum TG level in individuals with TC genotype lied in between the above two population groups. Subjects with rs964184 CC genotype had the lowest TG level, and the highest serum TG level was noted in those with rs964184 GG genotype. Conclusion Several SNPs were found to be related to the serum TG level in the Tibetan population. The APOA5 gene and MLXlPL gene may be closely associated with the serum TG level in this ethnic population group.

Dyslipidemia management in primary prevention of cardiovascular disease:Current guidelines and strategies

Cardiovascular disease is the leading cause of death in the United States. In 2010, the Centers for Disease Control and Prevention estimated that $444 billion was spent on cardiovascular diseases alone, about $1 of every $6 spent on health care. As life expectancy continues to increase, this annual cost will also increase, making costeffective primary prevention of cardiovascular disease highly desirable. Because of its role in development of atherosclerosis and clinical events, dyslipidemia management is a high priority in cardiovascular prevention. Multiple major dyslipidemia guidelines have been published around the world recently, four of them by independent organizations in the United States alone. They share the goal of providing clinical guidance on optimal dyslipidemia management, but guidelines differ in their emphasis on pharmacotherapy, stratification of groups, emphasis on lifestyle modification, and use of a fixed target or percentage reduction in low density lipoprotein cholesterol. This review summarizes eight major guidelines for dyslipidemia management and considers the basis for their recommendations. Our primary aim is to enhance understanding of dyslipidemia management guidelines in patient care for primary prevention of future cardiovascular risk.

2016 Chinese guidelines for the management of dyslipidemia in adults

Abbreviations ACS： acute coronary syndrome ALT： alanine aminotransferase Apo： apolipoprotein ASCVD： atherosclerotic cardiovascular disease AST： aspartate aminotransferase

Elevated Resting Heart Rate is Associated with Dyslipidemia in Middle-aged and Elderly Chinese

Objective To study the relationship between resting heart rate and blood lipid level. Methods A total of 9 415 subjects aged≥40 years were included in the present study. Their resting heart rate was monitored and their serum levels of triglyceride （TG）, total cholesterol （TC）, low density lipoprotein cholesterol （LDL-C） and high density lipoprotein cholesterol （HDL-C） were measured to define dyslipidemia according to the 2007 Chinese Guidelines on Prevention and Treatment of Dyslipidemia in Adults. Results The subjects were divided into group A with their resting heart rate〈70 beats/min, group B with their resting heart rate=70-79 beats/min, group C with their resting heart rate=80-89 beats/min, and group D with their resting heart rate≥90 beats/min. High TG, TC, and LDL-C were presented across the resting heart rate （Ptrend〈0.01）. Multiple logistic regression analysis revealed that the risk of high TG and TC was higher in subjects with their resting heart rate≥90 beats/min than in those with their resting heart rate〈70 beats/min （OR=1.42;95%CI：1.16-1.74 and OR=1.33;95%CI：1.09-1.64, respectively）. Conclusion Elevated resting heart rate is associated with high TG and TC in middle-aged and elderly Chinese subjects.

Post-transplant dyslipidemia: Mechanisms, diagnosis and management

Post-transplant dyslipidemia is highly prevalent and presents unique management challenges to the clinician. The two major outcomes to considerwith post-transplant therapies for dyslipidemia are preserving or improving allograft function, and reducing cardiovascular risk. Although there are other cardiovascular risk factors such as graft dysfunction, hypertension, and diabetes, attention to dyslipidemia is warranted because interventions for dyslipidemia have an impact on reducing cardiac events in clinical trials specific to the transplant population. Dyslipidemia is not synonymous with hyperlipidemia. Numerous mechanisms exist for the occurrence of posttransplant dyslipidemia, including those mediated by immunosuppressive drug therapy. Statin therapy has received the most attention in all solid organ transplant recipient populations, although the effect of proper dietary advice and adjuvant pharmacological and nonpharmacological agents should not be dismissed. At all stages of treatment appropriate monitoring strategies for side effects should be implemented so that the benefits from these therapies can be achieved. Clinicians have a choice when there is a conflict between various transplant society and lipid society guidelines for therapy and targets.

Elevated alanine aminotransferase activity is not associated with dyslipidemias,but related to insulin resistance and higher disease grades in non-diabetic non-alcoholic fatty liver disease

Objective:To explore demographic and metabolic factors associated with increased alanine aminotransferase(ALT)activity in non-diabetic non-alcoholic fatty liver disease(NAFLD)patients.Methods:Overall 372 patients who consecutively attended to Gastroenterology Clinic of Baqiyatallah University of Medical Sciences,Tehran,Iran awere diagnosed as NAFLD entered into analysis.Exclusion criteria were having diabetes mellitus and fasting blood glucose over126 mg/dL,active hepatitis B virus infection,having hepatitis C virus positive serology,and to be under corticosteroid therapy.ALT levels were considered pathologically high when it was over30 IU/L for men and over 19 IU/L for women.Results:Bivariate analyses using t test and chisquare test showed that patients with pathologically augmented ALT levels had significantly higher NAFLD grades in their ultrasonographic evaluations(P=0.003).Moreover,these patients represented significantly higher homeostatic model assessment levels(P=0.003),levels of serum insulin(P=0.002),fasting blood glucose(P<0.001),and uric acid(P=0.02).The prevalence of insulin resistance was also higher in patients with increased serum ALT concentrations.Multifactorial logistic regression models showed that ultrasonographic grading of NAFLD(P=0.027)and insulin resistance(P=0.013)were the only variables significantly associated with abnormal ALT levels.Conclusions:This study shows that the associations of increased ALT serum levels in NAFLD patients are different from what are supposed before.By excluding diabetic patients from our population,we find that increased ALT levels are not associated with dyslipidemias but are independently associated with insulin resistance and NAFLD grading on ultrasonographic evaluations.Further studies are needed to confirm our results.

Geographic Variations in the Prevalence,Awareness,Treatment,and Control of Dyslipidemia among Chinese Adults in 2018–2019:A Cross-sectional Study

Objective To investigate the spatial patterns of the prevalence,awareness,treatment,and control rates of dyslipidemia at the provincial level in China.Methods A national and provincial representative cross-sectional survey was conducted among 178,558 Chinese adults in 31 provinces in China's Mainland in 2018–2019,using a multi-stage,stratified,cluster-randomized sampling design.Subjects,as households,were selected,followed by a home visit to collect information.Both descriptive and linear regression procedures were applied in the analyses.Results The overall prevalence of dyslipidemia was 35.6%,and wide geographic variations of prevalence,treatment,and control rates of dyslipidemia were identified among 178,558 eligible participants with a mean age of 55.1±13.8 years.The highest-lowest difference regarding the provincial level prevalence rates were 19.7%vs.2.1%for high low-density lipoprotein cholesterol,16.7%vs.2.5%for high total cholesterol,35.9%vs.5.4%for high triglycerides,and 31.4%vs.10.5%for low high-density lipoprotein cholesterol.The treatment rate of dyslipidemia was correlated with the socio-demographic index(P<0.001),urbanization rate(P=0.01),and affordable basic technologies and essential medicines(P<0.001).Conclusion Prevailing dyslipidemia among the Chinese population and its wide geographic variations in prevalence,treatment,and control suggest that China needs both integrated and localized public health strategies across provinces to improve lipid management.

山橿中生物碱类成分Laetanine、Launobine对乙酸致GES-1细胞损伤的保护作用及机制

目的利用乙酸建立胃黏膜上皮细胞(GES-1细胞)损伤模型,研究山橿中生物碱类成分Laetanine、Launobine对GES-1细胞损伤的保护作用及机制。方法通过MTT细胞增殖/毒性实验确定Laetanine、Launobine的最佳给药浓度。分别以浓度为0.01%~0.2%的乙酸培养液作用于GES-1细胞,作用时间分别为3、4、5h,筛选最佳造模条件。利用乙酸建立GES-1细胞损伤模型,测定Laetanine、Launobine含药培养基处理后的细胞存活率;Griess法测定细胞上清液中NO的浓度;ELISA法测定各组细胞上清液中肿瘤坏死因子-α(TNF-α)、白细胞介素-6(IL-6)和前列腺素E2(PGE2)水平;WST-1法检测各实验组超氧化物歧化酶(SOD)抑制率,计算SOD活力值。结果0.1%乙酸溶液处理3h为GES-1细胞损伤的最佳造模条件;与模型组比较,Laetanine、Launobine给药组均能显著升高GES-1细胞存活率(P<0.01);经Laetanine、Launobine处理后,细胞上清液中的NO、TNF-α、IL-6和PGE2水平显著降低,SOD活力显著升高(P<0.01或P<0.05)。结论山橿中生物碱类成分Laetanine和Launobine均能保护乙酸损伤的GES-1细胞,减轻GES-1细胞的受损程度,其作用机制可能与其降低NO、TNF-α、IL-6和PGE2水平,升高SOD水平有关,表明Laetanine和Launobine可能为山橿发挥抗胃溃疡作用的有效成分。

Oxidative Stress and Dyslipidemia as Indicators of Pathogenesis of Preeclampsia in Pregnant Sudanese Women

Background: Preeclampsia (PE) still ranks as one of obstetrics major problems and is still a serious threat, mainly in underdeveloped countries where its incidence and mortality rates are higher and is a major cause of preterm birth and intra-uterine growth restriction. Aim: To evaluate the role of oxidative stress and dyslipidemia as indicators of pathogenesis and risks of preeclampsia in pregnant Sudanese women attending Wad-Medani Obstetrics and Gynecology Teaching Hospital. Material and Method: This was a cross-sectional (case-control) study carried out in preeclamptic pregnant Sudanese women attending Wad-Medani Obstetrics and Gynecology Teaching Hospital. A total of 208 pregnant women were enrolled in the study, 111 patients and 97 women with normal pregnancy as controls;pregnant women suffering from any systemic or endocrine disorder were excluded. We compared the serum levels of total cholesterol, LDL-cholesterol, HDL-cholesterol, triglycerides, nitric oxide, and total antioxidant capacity between preeclamptic and controls. Result and Conclusion: Pregnant women with increase in BMI have a higher chance of developing PE. Low level of high-density lipoprotein cholesterol and high level of low-density lipoprotein cholesterol define that dyslipidemia increases the risk of PE. Decreased levels of NO and TAC might reflect the oxidative stress and likely contribute to the pathophysiological mechanisms of PE.

基于FLUKA蒙卡程序模拟放射性核素^(68)Ge生产的产额研究

为了开展Ge-Ga发生器技术研究,需要开展^(68)Ge生产小试实验。本研究基于FLUKA蒙卡程序模拟了医用放射性核素68Ga的母体核素^(68)Ge的生产,计算了14、30、70 MeV质子束分别在100、200、500μA束流强度下照射富集69Ga的镓金属靶1、12、24 h后^(68)Ge的EOB(end of bombardment)产额,并对产额的变化以及靶上放射性核素活度进行分析。30 MeV/500μA质子束打靶24 h后^(68)Ge核素的EOB产额为3.13×10^(10) Bq,与70 MeV/500μA质子束的4.54×10^(10) Bq相当,但是靶上放射性杂质核素较少,30 MeV质子回旋加速器投入产出效益高。通过研究确定^(68)Ge核素生产的质子能量选择为30 MeV,可为^(68)Ge的生产小试实验及批量生产提供理论依据和技术支持。

基于gE蛋白的羊伪狂犬病病毒间接ELISA的建立与应用

为建立羊源伪狂犬病病毒(Pseudorabies virus,PRV)抗体的检测方法,从PRV中对gE基因进行克隆,并构建重组载体对gE蛋白进行原核表达,以重组gE蛋白为包被抗原,建立PRV抗体间接ELISA检测方法,并进行临床样本检测。结果显示,重组gE蛋白大小为42 ku,以包涵体形式表达;Western blot检测表明重组蛋白具有良好的反应原性;重组蛋白作为包被抗原的最佳工作浓度为1μg/mL,待检血清100倍稀释,以HRP标记的兔抗山羊IgG 10000倍稀释作为二抗;检测临床样本时判定阴阳性的临界值为0.284;灵敏性试验结果显示,羊PRV阳性血清稀释2048倍时检测结果仍为阳性;批内变异系数(2.45%~5.00%)与批间变异系数(2.55%~7.41%)均小于10%;采用建立的方法检测其他常见羊源病毒阳性血清结果均为阴性;对收集的376份临床羊血清进行检测,PRV阳性率为10.6%。建立的间接ELISA检测方法可用于羊源样本中伪狂犬病病毒抗体的检测,该方法的建立为羊场PRV抗体检测提供了技术支持。

基于中高能回旋加速器生产^(68)Ge核素的产额及产物模拟研究

^(68)Ge是正电子扫描(PET)诊断显像用放射性核素^(68)Ga的母体核素,^(68)Ge通过^(68)Ge/^(68)Ga发生器转化为^(68)Ga已在临床诊断显像中获得应用。国内目前有13种^(68)Ga标记的放射性药物已进入临床,在神经内分泌肿瘤、前列腺癌等肿瘤显像方面具有较好的应用前景。随着^(68)Ga放射性药物的获批和大量使用,^(68)Ge在国内外市场的应用前景广阔。此外,^(68)Ge也可以作为PET扫描仪的校准源而获得广泛使用。中国原子能科学研究院目前计划建造一台专用于放射性医用同位素生产、能量为75 MeV、最高束流流强800μA的强流质子回旋加速器,将重点开展^(68)Ge的生产。本研究利用蒙特卡罗程序FLUKA对中高能质子回旋加速器辐照镓镍合金靶和铌镓胶囊靶等方式生产^(68)Ge核素的产额、反应产物、杂质核素产额随冷却时间的变化、影响分离工艺的长寿命核素情况等进行详细模拟,本结果可为中高能质子回旋加速器生产^(68)Ge的生产和分离纯化提供参考。

砂仁挥发性成分及其对GES-1细胞保护作用的比较分析

目的:分析阳春砂、绿壳砂、海南砂及其伪品海南假砂的挥发性成分,比较四种砂仁挥发油对胃黏膜保护的活性。方法:采用顶空固相微萃取技术与气相色谱-质谱联用技术(HS-SPME-GC-MS),结合NIST08和NIST08s谱库对比定性色谱结果,分析4种砂仁的挥发性成分;采用面积归一化法,计算各挥发性成分的相对百分比含量,并进行主成分及热图分析;建立人胃黏膜上皮细胞(GES-1细胞)损伤模型,采用CCK-8法,对4种砂仁挥发油进行胃黏膜保护活性评价。结果:从阳春砂、绿壳砂、海南砂及其海南假砂中共检出114种化学成分,分别鉴定出57、58、58、58种成分,各占总挥发性成分相对百分比含量的93.23%、88.79%、90.87%、91.40%,其中总单萜烃类化合物各占总挥发性成分相对百分比含量的40.48%、37.77%、37.09%、33.39%,总倍半萜烃类化合物各占总挥发性成分相对百分比含量的52.53%、49.88%、31.22%、35.45%;阳春砂、绿壳砂、海南砂挥发油对乙醇致GES-1细胞损伤具有保护作用(P<0.05),海南假砂无明显活性。结论:阳春砂与绿壳砂的挥发性成分及含量差异较小,而海南砂、海南假砂与阳春砂、绿壳砂的挥发性成分及含量差异较大;阳春砂、绿壳砂、海南砂挥发油具有一定的胃黏膜保护活性。

GE LightSpeed Pro 16 CT伪影故障维修3例

介绍了GE LightSpeed Pro 16 CT的组成,分析了该设备出现的3例伪影故障的现象、原因并提出了具体的排除方法,为临床工程人员维修类似故障提供了参考。

七星关区耕地土壤Ge地球化学特征及其与作物的吸收关系

掌握耕地土壤Ge含量特征及其与作物的吸收关系,对耕地Ge的开发利用及科学选种具有重要意义。为此,以贵州省七星关区土地质量地球化学调查评价项目数据为基础,统计Ge的地球化学参数,分析该区土壤Ge地球化学特征和作物对Ge的吸收规律。结果显示:七星关区耕地土壤Ge含量在(0.86~2.48)×10^(-6),平均值1.74×10^(-6),与全国土壤Ge背景值相当。通过地统计分析,圈定富Ge耕地面积65853.54 hm^(2),占全区耕地总面积的47.41%,主要分布于研究区西北和西南部。农作物对土壤Ge的生物吸收系数(Ax)均小于1%,均处于极弱摄取水平。采用相关分析等方法讨论耕地土壤富Ge成因及影响作物吸收Ge的环境因子,得出以下结论:①土壤Ge含量主要受成土母质控制,同时受到风化成土过程的影响,并在七星关区耕地有机质含量丰富和偏酸性的土壤背景下,造成土壤Ge富集;②酸性土壤中,作物对土壤Ge的生物吸收系数(Ax)与pH呈弱负相关关系,而在中—碱性土壤中,作物对土壤Ge的生物吸收系数(Ax)与pH呈正相关关系,即偏酸性土壤是导致作物对Ge生物吸收能力低的原因。